Registered Tanzania · TMDA

hedralix

HEDERACOSIDE C 3.5 mg

TZ 20 HB 0002 Syrup

What it does

Hederacoside is a natural substance often used for its potential health benefits, especially in respiratory conditions.

Commonly used for: cough (tussis), bronchitis, chronic obstructive pulmonary disease (COPD)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TZ 20 HB 0002
Registration date
2025-03-17
Expiry date
2030-03-16
Status
Registered/Compliant
Active ingredient
HEDERACOSIDE C 3.5 mg
Dosage form
Syrup
Strength
-
Pack size
-
Therapeutic class
-
Country of origin
Oman
Manufacturer location
H649+JMW, Seeb, Oman

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:42:43 · updated 2026-10-19 03:00:44

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Hederacoside is a natural substance often used for its potential health benefits, especially in respiratory conditions.

What it treats

  • cough (tussis)
  • bronchitis
  • chronic obstructive pulmonary disease (COPD)

How it works

Hederacoside may help to loosen mucus in the airways and ease coughing.

Who it's for

It is generally used by individuals experiencing breathing difficulties or persistent cough.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: hederacoside

Hederacoside is a saponin glycoside derived from the plant Hedera helix, commonly known as English ivy. It is recognized for its potential therapeutic effects, particularly in respiratory ailments due to its mucolytic and expectorant properties. Hederacoside may also possess anti-inflammatory and antioxidant effects, contributing to its use in various medicinal applications.

Indications

  • Chronic obstructive pulmonary disease (COPD)
  • Asthma
  • Bronchitis
  • Respiratory infections

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing information.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing information.

Mechanism of action

Hederacoside exerts its pharmacological effects primarily through the stimulation of mucus secretion in the respiratory tract, which facilitates the clearance of mucus and improves respiratory function. This is achieved through its action on the bronchial mucosa, promoting expectoration and reducing cough reflex. Additionally, it may modulate inflammatory pathways, contributing to its anti-inflammatory effects.

Pharmacodynamics

Hederacoside demonstrates significant pharmacodynamic properties, such as increasing mucous secretion and promoting ciliary movement in the respiratory epithelium. Its anti-inflammatory effects may also involve the inhibition of pro-inflammatory cytokines and mediators, leading to reduced airway inflammation and improved respiratory function. The compound's antioxidant activity may protect lung tissue from oxidative stress, thereby enhancing overall respiratory health.

Pharmacokinetics

The pharmacokinetics of hederacoside include absorption, distribution, metabolism, and excretion characteristics that are still being studied. Generally, saponins like hederacoside are poorly absorbed in the gastrointestinal tract due to their complex structure. However, they can exert local effects within the gut and may undergo metabolism in the liver. Elimination typically occurs through biliary excretion, with a possible extensive first-pass metabolism.

Adverse effects

  • Gastrointestinal disturbances
  • Nausea
  • Diarrhea
  • Allergic reactions

Precautions

  • Use with caution in patients with known allergies to plants in the Asparagaceae family.
  • Monitor for adverse reactions in patients with gastrointestinal disorders.

Pregnancy

Limited data on safety during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Insufficient data on excretion in human milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Oral tablets
  • Powdered extracts
  • Capsules

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

Rwanda 1 product